High throughput screening has significantly contributed to advances in drug
discovery. The great increase in the number of samples screened has been a
ccompanied by increases in costs and in the data required for the investiga
ted compounds. High throughput profiling addresses the issues of compound s
electivity and specificity. It combines conventional screening with data mi
ning technologies to give a full set of data, enabling development candidat
es to be more fully compared.